Compare $BSX vs $IDXX | Chartloom

Compare

$BSX vs $IDXX

Boston Scientific Corp · IDEXX Laboratories Inc

BSX

Boston Scientific Corp

IDXX

IDEXX Laboratories Inc

Compare $BSX vs $IDXX

Comparing Boston Scientific Corp and IDEXX Laboratories Inc

BSXBoston Scientific Corp

IDXXIDEXX Laboratories Inc

BSXBoston Scientific Corp

Market cap

$63.51B

P/E (TTM)

17.15x

Forward P/E (NTM)

13.03x

Forward P/S (NTM)

2.93x

Rev growth (TTM)

13.5%

YTD performance

-54.9%

52W performance

-55.9%

FCF yield

5.7%

IDXXIDEXX Laboratories Inc

Market cap

$40.86B

P/E (TTM)

36.05x

Forward P/E (NTM)

32.49x

Forward P/S (NTM)

8.19x

Rev growth (TTM)

12.8%

YTD performance

-22.7%

52W performance

-17.8%

FCF yield

3.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BSX

IDXX

Detailed metrics comparison

BSX

Boston Scientific Corp

IDXX

IDEXX Laboratories Inc

Market Cap

BSX$63.51B

IDXX$40.86B

Enterprise Value

BSX$75.60B

IDXX$41.63B

Price

BSX$42.73

IDXX$518.00

P/E Ratio

BSX17.15x

IDXX36.05x

P/S Ratio

BSX3.02x

IDXX8.97x

EV/Sales

BSX3.60x

IDXX9.14x

EV/EBITDA

BSX12.63x

IDXX25.78x

P/B Ratio

BSX2.48x

IDXX25.33x

P/FCF Ratio

BSX17.52x

IDXX33.03x

EV/FCF

BSX20.85x

IDXX33.65x

PEG Ratio

BSX0.37x

IDXX2.78x

Forward P/E (NTM)

BSX13.03x

IDXX32.49x

Forward P/S (NTM)

BSX2.93x

IDXX8.19x

Revenue (TTM)

BSX$21.00B

IDXX$4.55B

Revenue Growth (YoY)

BSX13.5%

IDXX12.8%

Forward Rev Growth

BSX4.2%

IDXX8.8%

Gross Margin (TTM)

BSX69.5%

IDXX62.4%

Operating Margin (TTM)

BSX19.8%

IDXX32.0%

EBITDA Margin (TTM)

BSX27.7%

IDXX35.4%

Net Margin (TTM)

BSX17.5%

IDXX25.0%

FCF Margin (TTM)

BSX17.3%

IDXX27.2%

Net Income (TTM)

BSX$3.68B

IDXX$1.14B

FCF (TTM)

BSX$3.63B

IDXX$1.24B

EPS (TTM)

BSX$2.49

IDXX$14.37

ROE (TTM)

BSX14.9%

IDXX72.0%

ROA (TTM)

BSX8.3%

IDXX33.6%

ROIC (TTM)

BSX10.1%

IDXX45.1%

Cash

BSX$539M

IDXX$197M

Debt

BSX$12.62B

IDXX$969M

Net Cash/Debt

BSX$-12.09B

IDXX$-772M

Current Ratio (TTM)

BSX1.24x

IDXX1.17x

Quick Ratio (TTM)

BSX0.68x

IDXX0.82x

Debt/Equity (TTM)

BSX0.51x

IDXX0.60x

Debt/Assets (TTM)

BSX0.0%

IDXX0.0%

Interest Coverage (TTM)

BSXN/A

IDXXN/A

Net Debt/EBITDA (TTM)

BSX0.00x

IDXX0.00x

Beta

BSX0.59

IDXX1.56

52W Performance

BSX-55.9%

IDXX-17.8%

YTD Performance

BSX-54.9%

IDXX-22.7%

% from 52W High

BSX-59.6%

IDXX-32.7%

% from 52W Low

BSX3.2%

IDXX3.5%

Asset Turnover (TTM)

BSX0.48x

IDXX1.34x

FCF Yield (TTM)

BSX5.7%

IDXX3.0%

Earnings Yield (TTM)

BSX5.8%

IDXX2.8%

Dividend Yield (TTM)

BSXN/A

IDXXN/A

Rule of 40

BSX30.8

IDXX39.9

EV/GP/RG

BSX1.55

IDXX1.52

Ticker research

View BSX research View IDXX research

Metric	BSX Boston Scientific Corp	IDXX IDEXX Laboratories Inc
Market & Valuation
Market Cap	$63.51B	$40.86B
Enterprise Value	$75.60B	$41.63B
Price	$42.73	$518.00
P/E Ratio	17.15x	36.05x
P/S Ratio	3.02x	8.97x
EV/Sales	3.60x	9.14x
EV/EBITDA	12.63x	25.78x
P/B Ratio	2.48x	25.33x
P/FCF Ratio	17.52x	33.03x
EV/FCF	20.85x	33.65x
PEG Ratio	0.37x	2.78x
Forward P/E (NTM)	13.03x	32.49x
Forward P/S (NTM)	2.93x	8.19x
Revenue & Growth
Revenue (TTM)	$21.00B	$4.55B
Revenue Growth (YoY)	13.5%	12.8%
Forward Rev Growth	4.2%	8.8%
Profitability
Gross Margin (TTM)	69.5%	62.4%
Operating Margin (TTM)	19.8%	32.0%
EBITDA Margin (TTM)	27.7%	35.4%
Net Margin (TTM)	17.5%	25.0%
FCF Margin (TTM)	17.3%	27.2%
Net Income (TTM)	$3.68B	$1.14B
FCF (TTM)	$3.63B	$1.24B
EPS (TTM)	$2.49	$14.37
ROE (TTM)	14.9%	72.0%
ROA (TTM)	8.3%	33.6%
ROIC (TTM)	10.1%	45.1%
Financial Health
Cash	$539M	$197M
Debt	$12.62B	$969M
Net Cash/Debt	$-12.09B	$-772M
Current Ratio (TTM)	1.24x	1.17x
Quick Ratio (TTM)	0.68x	0.82x
Debt/Equity (TTM)	0.51x	0.60x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.59	1.56
52W Performance	-55.9%	-17.8%
YTD Performance	-54.9%	-22.7%
% from 52W High	-59.6%	-32.7%
% from 52W Low	3.2%	3.5%
Efficiency & Yields
Asset Turnover (TTM)	0.48x	1.34x
FCF Yield (TTM)	5.7%	3.0%
Earnings Yield (TTM)	5.8%	2.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	30.8	39.9
EV/GP/RG	1.55	1.52
Ticker research	View BSX research	View IDXX research

Valuation

P/E Ratio

BSX

17.15x

IDXX

36.05x

P/S Ratio

BSX

3.02x

IDXX

8.97x

EV/FCF

BSX

20.85x

IDXX

33.65x

Growth & revenue

Revenue Growth TTM

BSX

13.5%

IDXX

12.8%

Forward Revenue Growth

IDXX

8.8%

BSX

4.2%

Profitability & performance

Gross Margin

BSX

69.5%

IDXX

62.4%

ROE

IDXX

72.0%

BSX

14.9%

FCF Yield %

BSX

5.7%

IDXX

3.0%

52-Week Performance

IDXX

-17.8%

BSX

-55.9%

Detailed metrics comparison

BSX

Boston Scientific Corp

IDXX

IDEXX Laboratories Inc

Market Cap

BSX$63.51B

IDXX$40.86B

Enterprise Value

BSX$75.60B

IDXX$41.63B

Price

BSX$42.73

IDXX$518.00

P/E Ratio

BSX17.15x

IDXX36.05x

P/S Ratio

BSX3.02x

IDXX8.97x

EV/Sales

BSX3.60x

IDXX9.14x

EV/EBITDA

BSX12.63x

IDXX25.78x

P/B Ratio

BSX2.48x

IDXX25.33x

P/FCF Ratio

BSX17.52x

IDXX33.03x

EV/FCF

BSX20.85x

IDXX33.65x

PEG Ratio

BSX0.37x

IDXX2.78x

Forward P/E (NTM)

BSX13.03x

IDXX32.49x

Forward P/S (NTM)

BSX2.93x

IDXX8.19x

Revenue (TTM)

BSX$21.00B

IDXX$4.55B

Revenue Growth (YoY)

BSX13.5%

IDXX12.8%

Forward Rev Growth

BSX4.2%

IDXX8.8%

Gross Margin (TTM)

BSX69.5%

IDXX62.4%

Operating Margin (TTM)

BSX19.8%

IDXX32.0%

EBITDA Margin (TTM)

BSX27.7%

IDXX35.4%

Net Margin (TTM)

BSX17.5%

IDXX25.0%

FCF Margin (TTM)

BSX17.3%

IDXX27.2%

Net Income (TTM)

BSX$3.68B

IDXX$1.14B

FCF (TTM)

BSX$3.63B

IDXX$1.24B

EPS (TTM)

BSX$2.49

IDXX$14.37

ROE (TTM)

BSX14.9%

IDXX72.0%

ROA (TTM)

BSX8.3%

IDXX33.6%

ROIC (TTM)

BSX10.1%

IDXX45.1%

Cash

BSX$539M

IDXX$197M

Debt

BSX$12.62B

IDXX$969M

Net Cash/Debt

BSX$-12.09B

IDXX$-772M

Current Ratio (TTM)

BSX1.24x

IDXX1.17x

Quick Ratio (TTM)

BSX0.68x

IDXX0.82x

Debt/Equity (TTM)

BSX0.51x

IDXX0.60x

Debt/Assets (TTM)

BSX0.0%

IDXX0.0%

Interest Coverage (TTM)

BSXN/A

IDXXN/A

Net Debt/EBITDA (TTM)

BSX0.00x

IDXX0.00x

Beta

BSX0.59

IDXX1.56

52W Performance

BSX-55.9%

IDXX-17.8%

YTD Performance

BSX-54.9%

IDXX-22.7%

% from 52W High

BSX-59.6%

IDXX-32.7%

% from 52W Low

BSX3.2%

IDXX3.5%

Asset Turnover (TTM)

BSX0.48x

IDXX1.34x

FCF Yield (TTM)

BSX5.7%

IDXX3.0%

Earnings Yield (TTM)

BSX5.8%

IDXX2.8%

Dividend Yield (TTM)

BSXN/A

IDXXN/A

Rule of 40

BSX30.8

IDXX39.9

EV/GP/RG

BSX1.55

IDXX1.52

Ticker research

View BSX research View IDXX research

Metric	BSX Boston Scientific Corp	IDXX IDEXX Laboratories Inc
Market & Valuation
Market Cap	$63.51B	$40.86B
Enterprise Value	$75.60B	$41.63B
Price	$42.73	$518.00
P/E Ratio	17.15x	36.05x
P/S Ratio	3.02x	8.97x
EV/Sales	3.60x	9.14x
EV/EBITDA	12.63x	25.78x
P/B Ratio	2.48x	25.33x
P/FCF Ratio	17.52x	33.03x
EV/FCF	20.85x	33.65x
PEG Ratio	0.37x	2.78x
Forward P/E (NTM)	13.03x	32.49x
Forward P/S (NTM)	2.93x	8.19x
Revenue & Growth
Revenue (TTM)	$21.00B	$4.55B
Revenue Growth (YoY)	13.5%	12.8%
Forward Rev Growth	4.2%	8.8%
Profitability
Gross Margin (TTM)	69.5%	62.4%
Operating Margin (TTM)	19.8%	32.0%
EBITDA Margin (TTM)	27.7%	35.4%
Net Margin (TTM)	17.5%	25.0%
FCF Margin (TTM)	17.3%	27.2%
Net Income (TTM)	$3.68B	$1.14B
FCF (TTM)	$3.63B	$1.24B
EPS (TTM)	$2.49	$14.37
ROE (TTM)	14.9%	72.0%
ROA (TTM)	8.3%	33.6%
ROIC (TTM)	10.1%	45.1%
Financial Health
Cash	$539M	$197M
Debt	$12.62B	$969M
Net Cash/Debt	$-12.09B	$-772M
Current Ratio (TTM)	1.24x	1.17x
Quick Ratio (TTM)	0.68x	0.82x
Debt/Equity (TTM)	0.51x	0.60x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.59	1.56
52W Performance	-55.9%	-17.8%
YTD Performance	-54.9%	-22.7%
% from 52W High	-59.6%	-32.7%
% from 52W Low	3.2%	3.5%
Efficiency & Yields
Asset Turnover (TTM)	0.48x	1.34x
FCF Yield (TTM)	5.7%	3.0%
Earnings Yield (TTM)	5.8%	2.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	30.8	39.9
EV/GP/RG	1.55	1.52
Ticker research	View BSX research	View IDXX research